Health Care REITs LTC Properties (LTC) and Sabra Health Care REIT (SBRA) were upgraded at JMP, citing multiple tailwinds are ...
Sabra Health Care REIT rated buy, undervalued compared to peers. Investment-grade ratings, +7% dividend yield opportunity.
Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from ...
JMP Securities upgraded Sabra Health Care (SBRA) to Outperform from Market Perform with a $20 price target The firm expects “multiple ...
Jefferies lowered the firm’s price target on Sabra Health Care to $20 from $21 and keeps a Buy rating on the shares as part ...
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management picked Sabra Health Care REIT, Inc. as her final trade.
In a report released today, Aaron Hecht from JMP Securities upgraded Sabra Healthcare REIT (SBRA – Research Report) to a Buy, with a price ...
JPMorgan Chase & Co. lifted its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 222.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 9,886,917 ...